RE:Re curiousThe whole sector is suffering, with VRX tumbling yesterday the negativity is still very strong. As long as VRX is crumbling, it will be hard for CXR to get a good upward momentum without any fake buyout rumour.
Right now smart money doesn't believe in forward guidance and only a few perfect quarters will set things straight. There's a real risk guidance won't be achieved with all the political stuff potentially affecting the business.
I personally expect lower results than expected over the next 12 months, but still good enough to price this stock at much higher than what it is today. We shall see.
astuteinvestor1 wrote: What if there was no talk of BO. Where would the stock be trading $10 or $15. If so why. What's changed since the acquistion of Amdipharm other than the debt.